Cariprazine in Three Acute Patients with Schizophrenia: A Real-World Experience

There are still some unmet needs in the treatment of schizophrenia like the persistence of negative symptoms. Cariprazine is a new-generation antipsychotic with partial agonism of the dopamine receptors, distinct from other antipsychotics by its 10 times greater affinity for D3 receptors. This mecha...

Descripción completa

Detalles Bibliográficos
Autores principales: Montes, Jose M, Montes, Paloma, Hernández-Huerta, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868213/
https://www.ncbi.nlm.nih.gov/pubmed/33568908
http://dx.doi.org/10.2147/NDT.S298005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868213/
https://www.ncbi.nlm.nih.gov/pubmed/33568908
http://dx.doi.org/10.2147/NDT.S298005

Ejemplares similares